Pan Cancer T raises funds through seed extension round
The funding will facilitate the completion of preclinical studies for its leading product, PCT1:CO-STIM.
Cancer
Pentixapham acquires antibody discovery business from Glycotope
EHA 2024: Roche’s Columvi competes in BiTE battle with positive results in DLBCL
Study touts targeted chemotherapy delivery method using “chicken feather” protein
Prothea debuts with $13m to develop cancer diagnostics and treatment
Touchlight joins forces with University of Liverpool for NSCLC vaccine
Are we there yet? The future of cancer treatment
Biocytogen and Radiance partner for bispecific antibody-drug conjugate
